Table 2 The average capsule transit time and gastrointestinal lesions in patients with systemic sclerosis.
Variables | Total, n = 65 | Types | P-values | |
|---|---|---|---|---|
dcSSc, n = 31 | lcSSc, n = 34 | |||
Total small-bowel observation rate | 68% (44/65) | 65% (20/31) | 71% (24/34) | 0.6011 |
Transit time (min) | ||||
Esophagus | 12.6 [1–238] | 16.0 [1–238] | 3.8 [1–29] | 0.0418 |
Stomach | 35.8 [1–175] | 35.2 [1–175] | 36.4 [1–147] | 0.1904 |
Small bowel | 265.9 [136–430] | 268.5 [136–428] | 263.7 [145–430] | 0.8412 |
Gastrointestinal lesions | ||||
Esophagus | ||||
Reflux esophagitis | 10 (15) | 4 (13) | 6 (17) | 0.5951 |
SSBE | 5 (8) | 2 (6) | 3 (9) | 0.7189 |
Stomach | ||||
GAVE | 5 (8) | 4 (13) | 1 (3) | 0.1221 |
Small-bowel | ||||
Angioectasia | 13 (20) | 4 (13) | 9 (26) | 0.0797 |
Type 1a | 7 (11) | 4 (13) | 3 (× 9) | 0.7859 |
Type 1b | 6 (9) | 0 (0) | 6 (17) | 0.0071 |
Erosion/ulceration | 14 (22) | 9 (29) | 5 (15) | 0.1589 |
